Development of ultra-miniaturized weak affinity chromatography coupled to mass spectrometry as a high throughput fragment screening method against wild-type and purified membrane proteins embedded in biomimetic membranes

IF 5.7 2区 化学 Q1 CHEMISTRY, ANALYTICAL
François-Xavier Vidal , Julie Gil , Maud Gregson , Gabrielle Zeder-Lutz , Maria Hideux , Jérôme Lemoine , Isabelle Krimm , Renaud Wagner , Vincent Dugas , Claire Demesmay
{"title":"Development of ultra-miniaturized weak affinity chromatography coupled to mass spectrometry as a high throughput fragment screening method against wild-type and purified membrane proteins embedded in biomimetic membranes","authors":"François-Xavier Vidal ,&nbsp;Julie Gil ,&nbsp;Maud Gregson ,&nbsp;Gabrielle Zeder-Lutz ,&nbsp;Maria Hideux ,&nbsp;Jérôme Lemoine ,&nbsp;Isabelle Krimm ,&nbsp;Renaud Wagner ,&nbsp;Vincent Dugas ,&nbsp;Claire Demesmay","doi":"10.1016/j.aca.2025.343950","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Membrane proteins, which make up approximately 30 % of the proteome, are important drug targets but present many challenges in drug discovery, including limited production rates, low final yields of pure and functionally folded proteins, and instability in aqueous media. The problems encountered with membrane proteins are even more critical in the Fragment Based Drug Discovery, where the discovery of potential drug candidates is hampered by the limited availability of efficient methods for rapid screening of weak fragment-protein interactions.</div></div><div><h3>Results</h3><div>In this work, we propose the coupling of miniaturized weak affinity chromatography with mass spectrometry (nano-WAC-MS) as an innovative strategy for the rapid screening of fragments capable of weak binding to a selected membrane protein. An integral membrane protein (AA<sub>2A</sub>R) was incorporated into biotinylated nanodiscs, which were subsequently immobilized on a miniaturized monolithic streptavidin column (75 μm i.d., 300 nL volume). The coupling of these miniaturized affinity columns (each consuming less than 1 μg of protein) to mass spectrometry (MRM mode) has been optimized to maximize the low affinity range and increase throughput so that 150 fragments can be injected in a single analysis, with a DMSO content as high as 10 %, with no influence on the affinity. Hits are identified by comparing their retention with that measured on control columns prepared with empty nanodiscs.</div></div><div><h3>Significance</h3><div>The results of this screening are compared with those obtained by NMR and newly identified hits are confirmed by either competition experiments or frontal affinity experiments. We show that this nanodisc-based strategy, which provides a stable and native-like lipid environment for the protein (columns can be used for several days), should also work with other membrane proteins embedded in nanodiscs.</div></div>","PeriodicalId":240,"journal":{"name":"Analytica Chimica Acta","volume":"1353 ","pages":"Article 343950"},"PeriodicalIF":5.7000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analytica Chimica Acta","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0003267025003447","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Membrane proteins, which make up approximately 30 % of the proteome, are important drug targets but present many challenges in drug discovery, including limited production rates, low final yields of pure and functionally folded proteins, and instability in aqueous media. The problems encountered with membrane proteins are even more critical in the Fragment Based Drug Discovery, where the discovery of potential drug candidates is hampered by the limited availability of efficient methods for rapid screening of weak fragment-protein interactions.

Results

In this work, we propose the coupling of miniaturized weak affinity chromatography with mass spectrometry (nano-WAC-MS) as an innovative strategy for the rapid screening of fragments capable of weak binding to a selected membrane protein. An integral membrane protein (AA2AR) was incorporated into biotinylated nanodiscs, which were subsequently immobilized on a miniaturized monolithic streptavidin column (75 μm i.d., 300 nL volume). The coupling of these miniaturized affinity columns (each consuming less than 1 μg of protein) to mass spectrometry (MRM mode) has been optimized to maximize the low affinity range and increase throughput so that 150 fragments can be injected in a single analysis, with a DMSO content as high as 10 %, with no influence on the affinity. Hits are identified by comparing their retention with that measured on control columns prepared with empty nanodiscs.

Significance

The results of this screening are compared with those obtained by NMR and newly identified hits are confirmed by either competition experiments or frontal affinity experiments. We show that this nanodisc-based strategy, which provides a stable and native-like lipid environment for the protein (columns can be used for several days), should also work with other membrane proteins embedded in nanodiscs.

Abstract Image

Abstract Image

背景膜蛋白约占蛋白质组的 30%,是重要的药物靶点,但在药物发现方面却面临着许多挑战,包括生产率有限、纯蛋白和功能折叠蛋白的最终产量低以及在水介质中的不稳定性。结果在这项工作中,我们提出了微型化弱亲和层析与质谱联用(nano-WAC-MS)的创新策略,用于快速筛选能与所选膜蛋白弱结合的片段。一种整体膜蛋白(AA2AR)被纳入生物素化的纳米盘,随后被固定在小型化的链霉亲和素整体柱(内径 75μm,体积 300 nL)上。这些微型亲和柱(每个消耗不到 1 微克蛋白质)与质谱(MRM 模式)的耦合经过优化,最大限度地扩大了低亲和力范围并提高了通量,因此在一次分析中可以注入 150 个片段,DMSO 含量高达 10%,而对亲和力没有任何影响。我们将筛选结果与核磁共振得出的结果进行了比较,并通过竞争实验或正面亲和力实验确认了新识别出的靶点。我们的研究表明,这种基于纳米盘的策略能为蛋白质提供稳定的、类似于原生脂质的环境(色谱柱可使用数天),因此也适用于嵌入纳米盘的其他膜蛋白。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Analytica Chimica Acta
Analytica Chimica Acta 化学-分析化学
CiteScore
10.40
自引率
6.50%
发文量
1081
审稿时长
38 days
期刊介绍: Analytica Chimica Acta has an open access mirror journal Analytica Chimica Acta: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. Analytica Chimica Acta provides a forum for the rapid publication of original research, and critical, comprehensive reviews dealing with all aspects of fundamental and applied modern analytical chemistry. The journal welcomes the submission of research papers which report studies concerning the development of new and significant analytical methodologies. In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and impact of the research and the extent to which it adds to the existing body of knowledge in analytical chemistry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信